This portal is a part of
Company Database with
  • 24'017 Companies
  • 25'015 Biotech / Medtech Products
  • 3'405 Financing rounds
  • 279 Company valuations
  • 32'810 Management details
  • 5'529 Licensing opportunities
Licensing Deals Database with
  • 1'405 Deals each with financial information
  Global Events
  		• May 2012 - Toronto:
    BioFinance 2012
  		• May 2012 - Paris:
    Euro-Biotech Partnering Summit
  		• Jun 2012 - Zurich:
    The Pharma Business Development Course
      Add Event
      Latest news
  		• 16 April 2012
    Canadian study finds doctor incentives aren’t helping patients
  		•  11 April 2012
    Bioniche Life Sciences Inc. Closes US$20M Financing from Capital Royalty L.P.
  		•  05 April 2012
    Biotech Challenge Canada Asks Youth "How Will You Change the World?" Through Science
      Partners
    NEWS IN THE LIFE SCIENCES INDUSTRY
    Results 1 - 10 of 57


        1  |   2   |   3   |   4   |   5   |   6     Next  ››
     
    Canadian study finds doctor incentives aren’t helping patients
    The hundreds of millions of dollars provinces have spent recently on incentive payments to convince doctors to provide better care do not seem to actually work, suggests a new study that calls into question an increasingly popular — and expensive — pillar of health reform. The University of... [Read more...]
    By: National Post - 16 Apr 2012
     
     
    Bioniche Life Sciences Inc. Closes US$20M Financing from Capital Royalty L.P.
    Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has closed a US$20 million financing from investment funds managed by U.S.-based Capital Royalty L.P. (Capital Royalty). The funds have been transferred... [Read more...]
    By: Stockhouse - 11 Apr 2012
     
     
    Biotech Challenge Canada Asks Youth "How Will You Change the World?" Through Science
    National biotechnology research competition encourages Canadian youth to pursue future studies and careers in Canada's $86 billion biotechnology industry TORONTO - How will you change the world? That question has been the inspiration for hundreds of students across Canada to compete in the "2012... [Read more...]
    By: Exchange Magazine - 05 Apr 2012
     
     
    SemBioSys announces voluntary delisting from Toronto Stock Exchange and pursuit of strategic alterna
    CALGARY, April 4, 2012 /CNW/ - SemBioSys Genetics Inc. ("SemBioSys" or the "Company") (TSX:SBS), a development stage biotechnology company that utilizes its  proprietary safflower based technology platform to develop high value proteins and other products, today announced it has applied to voluntarily... [Read more...]
    By: Canada Newswire - 05 Apr 2012
     
     
    Valeant moving HQ to Montreal from Toronto area
    MISSISSAUGA, Ont. — Canada's largest publicly traded drug company is moving its global headquarters to Montreal from the Toronto area. Valeant Pharmaceuticals International, Inc. (TSX:VRX) has had its head office in Mississauga, Ont., since Biovail Corp. merged with California-based Valeant. Since... [Read more...]
    By: CTV News - 05 Apr 2012
     
     
    Canadians "waiting two-and-a-half years for new drugs"
    In 2010, Canada's drug regulator took 527 days, on average, to certify new drugs as safe and effective, while the nation's provinces added another 358 days to approve them for coverage under public drug plans, says a new study. "This bureaucratic layering creates unnecessary delays and deprives... [Read more...]
    By: Pharma Times - 05 Apr 2012
     
     
    $7.6 million for the McGill University and Génome Québec Innovation Centre: record funding for QC
    MONTREAL, April 4, 2012 /CNW Telbec/ - The McGill University and Génome Québec Innovation Centre is pleased to announce that they have been awarded funding totalling $7.6 million over a two-year period from Genome Canada's 2010 Competition: Science and Technology Innovation Centre Operations... [Read more...]
    By: Canada Newswire - 05 Apr 2012
     
     
    Genetic code of most deadly breast cancer deciphered
    Canadian researchers announced Wednesday they have figured out the genetic makeup of the deadliest form of breast cancer, a breakthrough that may one day help doctors devise a treatment plan that better targets their patients' disease. Scientists at the BC Cancer Agency said the genetic code for... [Read more...]
    By: CTV News - 05 Apr 2012
     
     
    U of G Scientists Clone ‘Survivor’ American Elm Trees
    Scientists at the University of Guelph have found a way to successfully clone American elm trees that have survived repeated epidemics of their biggest killer — Dutch elm disease. The breakthrough, published today in the Canadian Journal of Forest Research, is the first known use of in vitro... [Read more...]
    By: University of Guelph - 30 Mar 2012
     
     
    Vaccine in works to combat respiratory illness RSV
    Researchers at the University of Saskatchewan say they are close to developing a vaccine to fight respiratory syncytial virus (RSV), a highly contagious infection that can be life-threatening to children. Sylvia van den Hurk, a professor of microbiology and immunology at the university's college... [Read more...]
    By: CBC News - 30 Mar 2012
     
    Results 1 - 10 of 57


        1  |   2   |   3   |   4   |   5   |   6     Next  ››